Efficacy and safety of sintilimab plus bevacizumab in metastatic nasopharyngeal carcinoma after failure of platinum-based chemotherapy: an open-label phase 2 study.

Nian Lu,Yao-Fei Jiang,Wei-Xiong Xia,Ying Huang,Chuan-Miao Xie,Cheng Xu,Yan-Fang Ye,Guo-Ying Liu,Wei-Xin Bei,Liang-Ru Ke,Wang-Zhong Li,Cheng Zhang,Xin Wang,Qin Liu,Xi Chen,Zi-Xiong Chen,Changqing Xie,Hu Liang,Yan-Qun Xiang

EClinicalMedicine（2023）

引用 0|浏览22

暂无评分

摘要

The Guangdong Basic and Applied Basic Research Foundation, the National Natural Science Foundation of China, the Natural Science Foundation of Guangdong Province, and the Science and Technology Planning Project of International Cooperation of Guangdong Province.

查看译文

关键词

metastatic nasopharyngeal carcinoma,bevacizumab,chemotherapy,sintilimab,platinum-based,open-label

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要